Everyone hopes that the long -awaited cervical cancer vaccine will finally be listed in China。

 

  Yesterday，Published information on the State Food and Drug Administration，Calculating July 12，The State Food and Drug Administration approves the anti -use biological product & mdash; human papilloma virus adsorption vaccine import application。This product uses a rod -like virus expression system to express the reorganization HPV16 and 18 L1 virus -like particles，Puritization，Dual -valent vaccine prepared by mpl and aluminum hydroxide agent。

 

  This vaccine is the first new vaccine applied for stake betting applisting stake sports betting appin my country，Research data shows that the safety and effectiveness of applications in domestic target groups are consistent with foreign countries。Approval of the vaccine，It provides new effective means for the prevention of cervical cancer in my country。

 

  GSK China's official WeChat representation，Herry & reg;，Use 3 dose immunization procedures，And is expected to be officially launched in early next year。

 

  HPV vaccine is the world's first cancer prevention vaccine，Can prevent women's cervical cancer。In our country，Cervical cancer is the second largest female cancer after breast cancer，150,000 diseases per year，80,000 deaths。and 99.7%of cervical cancer are caused by HPV virus infection，So，As long as it can prevent the infection of HPV virus，can avoid most of the cervical cancer。

 

  The approval of the prevention of cervical cancer vaccine in GlaxoSmithk will drive out the outbreak of related markets。Founder Securities released relevant research report yesterday，Research Report Analysis believes，Prevention of cervical cancer market，At least 10 billion markets。Previous，Since the GSK vaccine has not been listed in China，Nearly 2 Stake Sports Bettingmillion stake online sports bettingpeople go to Hong Kong to inject vaccines every year。

 

  GSK's cervical cancer vaccine is finally approved

 

  It is understood，At present, there are two vaccines that prevent cervical cancer.，is the Gardasil and CERVARIX of the GSK，They have been approved in the United States in 2006 and 2009.，Where，Merhado's vaccine is four -price，My stake betting appPrevention stake online sports betting16、18、6、type 11 HPV virus，GSK is a two -price，Prevention 16、type 18 HPV virus。Although it does not cover all HPV virus subtypes，But 70%of cervical cancer and 16、type 18 related。6、type 11 may be related to diseases such as condyloma acuminatum。

 

  Cervarix of Grandulsk in 2005 began to declare clinical in China， When the FDA approval was not approved in 2008，It has begun to recruit volunteers in China，Prepare to enter the Chinese market。

 

  The reason why progress is slow，Mainly the clinical end point of the my country Drug Examination Center is cancer or a cervical epithelium in the cervical epithelium，This leads to at least 5 years of clinical trials。and the clinical ending of WHO and the United States and Europe is the continuous infection of HPV virus

 

  Cui Wenliang, chief medical analyst of Founder Securities, said in the relevant research report，We think，GSK's products are approved，Not only a GSK company benefits，but has a milestone meaning，Explain that the standard of CFDA approval HPV and clinical observation endpoints have begun to move closer to international standards，It is a major good for subsequent reviews and research companies!

 

  Other vaccines may be approved quickly

 

  According to the research report of Founder Securities，Gardasil of Merhado received clinical trial approval in 2007; starting February 2009，A three -year clinical trial at the obstetrics and gynecology hospital affiliated to Zhejiang University Medical College，The number of participants is 6,000; in 2012, the domestic III clinical stake sports betting apptrial stake sports betting appwas completed in 2012，and submitted an import application。

 

  However, after III test is done，CFDA is based on the fact that the data of more than secondary tumor changes is not enough，Requirement test。As far as we understand，At present, Merck has completed the Gardasil extension test，Enter the final review stage。According to the sales of the international HPV vaccine and clinical effects，Founder Securities believes that the Gardasil of Merhado is also expected to be approved later。

 

  It is understood，Listed Company Zhifei Bio signed an exclusive agency agreement with Meridodon in 2012，Once Merhado's products are approved，​​It is a good for Zhifei creatures。The HPV vaccine of Zerun Bio, a subsidiary of Watson Biology, has entered the third phase of the clinic，or may also benefit from changes in CFDA approval conditions。

 

  Preventing HPV vaccine market: at least tens of billions of

 

  The HPV vaccination approved by the US FDA is 9 to 26 years old women，If my country also adopts the same standard，The total number of related crowds is 143 million people。GSK's CERVARIX only needs to be two times for those 9 to 14 years old，More than 14 years old needs to be vaccinated 3 times。

 

  If the price of 3,000 Hong Kong dollars/three stitches in Hong Kong HPV vaccine，According to the 10%market penetration rate，my country's HPV vaccine potential market space is about 35 billion yuan，If the penetration rate is based on 30%assumption，corresponding to the market space reaches 100 billion levels。

 

  Another，It is reported，my country's nearly 2 Stake Sports Bettingmillion stake online sports bettingpeople go to Hong Kong to get HPV vaccines each year，So，HPV vaccine after stake betting applisting in my country，Just the corresponding sales scale corresponding to these people is at least 5 billion yuan。